Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Phase II trial of WT1 analog peptide vaccine in...
Conference

Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR).

Authors

Maslak PG; Dao T; Bernal Y; Chanel SM; Zhang R; Frattini MG; Rosenblat TL; Jurcic JG; Rampal R; Park JH

Volume

34

Pagination

pp. 7005-7005

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2016

DOI

10.1200/jco.2016.34.15_suppl.7005

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X